Mercer Global Advisors
FBIO icon

Mercer Global Advisors’s Fortress Biotech FBIO Stock Holding History

Mercer Global Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,033
Closed -$144K – 1638
2020
Q4 		$144K Buy
+3,033
New +$131K ﹤0.01% 1278

Other funds holding FBIO

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Mercer Global Advisors's FBIO Position: Q1 2021 in Review

Mercer Global Advisors sold out of Fortress Biotech (FBIO) in Q1 2021, closing a stake of 3,033 shares — an estimated $144K sold.

Mercer Global Advisors first reported a position in FBIO in Q4 2020 and held it in 1 quarter. The position peaked at $144K in Q4 2020. 85 funds tracked by Wall St. Rank hold FBIO as of Q1 2021.

  • Mercer Global Advisors reported no remaining Fortress Biotech position as of Q1 2021 after selling out during the quarter.
  • Mercer Global Advisors sold 3,033 Fortress Biotech shares in Q1 2021, an estimated $144K.
  • Mercer Global Advisors first reported a position in Fortress Biotech in Q4 2020 and held it in 1 quarter.
  • Mercer Global Advisors's Fortress Biotech position peaked at $144K in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2021.

Based on Mercer Global Advisors's 13F filing for Q1 2021, filed 11 May 2021.